JP2008509950A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509950A5
JP2008509950A5 JP2007526351A JP2007526351A JP2008509950A5 JP 2008509950 A5 JP2008509950 A5 JP 2008509950A5 JP 2007526351 A JP2007526351 A JP 2007526351A JP 2007526351 A JP2007526351 A JP 2007526351A JP 2008509950 A5 JP2008509950 A5 JP 2008509950A5
Authority
JP
Japan
Prior art keywords
phenyl
dioxo
imidazolidin
thiazol
butyramide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007526351A
Other languages
English (en)
Japanese (ja)
Other versions
JP4927733B2 (ja
JP2008509950A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/008633 external-priority patent/WO2006018188A2/en
Publication of JP2008509950A publication Critical patent/JP2008509950A/ja
Publication of JP2008509950A5 publication Critical patent/JP2008509950A5/ja
Application granted granted Critical
Publication of JP4927733B2 publication Critical patent/JP4927733B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007526351A 2004-08-17 2005-08-09 置換ヒダントイン Expired - Fee Related JP4927733B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US60217504P 2004-08-17 2004-08-17
US60/602,175 2004-08-17
US68299705P 2005-05-20 2005-05-20
US60/682,997 2005-05-20
PCT/EP2005/008633 WO2006018188A2 (en) 2004-08-17 2005-08-09 Substituted hydantoins

Publications (3)

Publication Number Publication Date
JP2008509950A JP2008509950A (ja) 2008-04-03
JP2008509950A5 true JP2008509950A5 (https=) 2012-01-05
JP4927733B2 JP4927733B2 (ja) 2012-05-09

Family

ID=35589619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007526351A Expired - Fee Related JP4927733B2 (ja) 2004-08-17 2005-08-09 置換ヒダントイン

Country Status (16)

Country Link
US (1) US7427635B2 (https=)
EP (1) EP1781649B1 (https=)
JP (1) JP4927733B2 (https=)
KR (2) KR20090006885A (https=)
AR (1) AR050297A1 (https=)
AT (1) ATE404556T1 (https=)
AU (1) AU2005274390B2 (https=)
BR (1) BRPI0514515A (https=)
CA (1) CA2576599A1 (https=)
DE (1) DE602005008986D1 (https=)
ES (1) ES2313389T3 (https=)
MX (1) MX2007001846A (https=)
PL (1) PL1781649T3 (https=)
RU (1) RU2383542C2 (https=)
TW (1) TW200621764A (https=)
WO (1) WO2006018188A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200621766A (en) * 2004-09-17 2006-07-01 Hoffmann La Roche Substituted hydantoins
US7612212B2 (en) * 2006-02-22 2009-11-03 Hoffmann-La Roche Inc. Substituted hydantoins
JP2010526848A (ja) * 2007-05-11 2010-08-05 エフ.ホフマン−ラ ロシュ アーゲー 難溶性薬物用の医薬組成物
ATE551336T1 (de) 2007-08-16 2012-04-15 Hoffmann La Roche Substituierte hydantoine
JP2011506533A (ja) 2007-12-20 2011-03-03 エフ.ホフマン−ラ ロシュ アーゲー Mekキナーゼ阻害剤としての置換ヒダントイン
MX2010014066A (es) * 2008-06-16 2011-06-01 Univ Tennessee Res Foundation Compuestos para el tratamiento del cancer.
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
WO2010068738A1 (en) 2008-12-10 2010-06-17 Dana-Farber Cancer Institute, Inc. Mek mutations conferring resistance to mek inhibitors
TW201113280A (en) * 2009-07-03 2011-04-16 Nensius Res As Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the CNS
ES2576061T3 (es) 2010-02-25 2016-07-05 Dana-Farber Cancer Institute, Inc. Mutaciones de BRAF que confieren resistencia a inhibidores de BRAF
JP5879273B2 (ja) 2010-03-01 2016-03-08 ジーティーエックス・インコーポレイテッド 癌を処置するための化合物
BR112012022801B8 (pt) 2010-03-09 2019-10-29 Dana Farber Cancer Inst Inc método de identificar um indivíduo que tem câncer que é provável beneficiar-se do tratamento com uma terapia de combinação com um inibidor de raf e um segundo inibidor e uso de um inibidor de raf e um segundo inibidor para a fabricação de um medicamento para tratar câncer
JP5960683B2 (ja) 2010-04-28 2016-08-02 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 殺真菌剤としてのケトヘテロアリールピペリジンおよび−ピペラジン誘導体
US20150141470A1 (en) 2012-05-08 2015-05-21 The Broad Institute, Inc. Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy
JP7235859B2 (ja) * 2018-09-17 2023-03-08 ユンジン ファーム.カンパニー、リミテッド 新規なチアゾール誘導体及びその薬学的に許容される塩
EP4119556A1 (en) * 2020-03-13 2023-01-18 Yungjin Pharm. Co., Ltd. Pharmaceutical composition for preventing or treating cancer comprising azole derivatives or pharmaceutically acceptable salt thereof
WO2021182914A1 (ko) * 2020-03-13 2021-09-16 영진약품 주식회사 신규한 cdk7 억제 화합물 및 이의 약제학적으로 허용가능한 염
KR20210146144A (ko) 2020-05-26 2021-12-03 엘지전자 주식회사 카트부

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770573A (en) * 1993-12-06 1998-06-23 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same
NZ501276A (en) 1997-07-01 2000-10-27 Warner Lambert Co 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
AU5227001A (en) * 2000-05-03 2001-11-12 Hoffmann La Roche Hydantoin-containing glucokinase activators
JP2004534857A (ja) * 2001-07-19 2004-11-18 フアルマシア・イタリア・エツセ・ピー・アー フェニルアセトアミド−チアゾール誘導体、それらの製造のための方法及び抗癌剤としてのそれらの使用

Similar Documents

Publication Publication Date Title
JP2008509950A5 (https=)
JP5675773B2 (ja) Ccr2の4−アゼチジニル−1−フェニル−シクロヘキサンアンタゴニスト
ES2240558T3 (es) Derivados de tiazol y oxazol como activadores de receptores activados por el proliferador de peroxisoma humano.
JP5244863B2 (ja) ジオキサン−2−アルキルカルバメート誘導体の製造法およびその中間体
RU2383542C2 (ru) Замещенные гидантоины
RU2007116317A (ru) Гексафторизопропанол-замещенные производные простых эфиров
JP2007523905A5 (https=)
JP2018531982A5 (https=)
JP2009508963A5 (https=)
JP2009538333A5 (https=)
JP2005511766A5 (https=)
JP2007519692A5 (https=)
JP4796046B2 (ja) ピペリジニルアルキルカーバメートの誘導体、これらの製造方法及びfaah酵素インヒビターとしての使用
JP2006506380A5 (https=)
AU2010236336B2 (en) 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2
JP2010504323A5 (https=)
JP2004507501A5 (https=)
JP2014523400A5 (https=)
KR101972619B1 (ko) 페닐 유도체
JP2024512818A5 (https=)
CA2598516A1 (en) Benzisoxazole derivatives
JP2021535895A5 (https=)
JP2008540595A5 (https=)
KR20140117301A (ko) 페닐 유도체를 함유하는 의약
JP2024543451A5 (https=)